Susquehanna International Group, LLP Evogene Ltd. Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Evogene Ltd. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 61,351 shares of EVGN stock, worth $140,493. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,351

Previous 32,495 88.8%

Holding current value

$140,493

Previous $24,000 62.5%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$0.61 - $0.82 $17,602 - $23,661	28,856 Added 88.8%	61,351 $39,000
Q1 2024 May 07, 2024	BUY	$0.7 - $0.98 $5,715 - $8,001	8,165 Added 33.56%	32,495 $24,000
Q4 2023 Feb 14, 2024	BUY	$0.47 - $0.88 $11,435 - $21,410	24,330 New	24,330 $20,000
Q1 2023 May 16, 2023	SELL	$0.59 - $0.86 $1,227 - $1,789	-2,081 Reduced 14.5%	12,271 $7,000
Q4 2022 Feb 14, 2023	BUY	$0.61 - $8.13 $8,754 - $116,681	14,352 New	14,352 $10,000
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $9,900 - $17,557	-13,201 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.09 - $1.83 $42,359 - $71,117	-38,862 Reduced 74.64%	13,201 $17,000
Q4 2021 Feb 14, 2022	SELL	$1.63 - $2.83 $23,048 - $40,016	-14,140 Reduced 21.36%	52,063 $85,000
Q3 2021 Nov 15, 2021	BUY	$2.45 - $3.45 $54,257 - $76,403	22,146 Added 50.27%	66,203 $175,000
Q2 2021 Aug 11, 2021	SELL	$3.3 - $5.02 $42,385 - $64,476	-12,844 Reduced 22.57%	44,057 $151,000
Q1 2021 May 17, 2021	BUY	$4.29 - $9.94 $130,922 - $303,348	30,518 Added 115.67%	56,901 $287,000
Q4 2020 Feb 16, 2021	BUY	$2.41 - $5.63 $26,685 - $62,340	11,073 Added 72.33%	26,383 $124,000
Q3 2020 Nov 16, 2020	BUY	$0.97 - $4.08 $14,850 - $62,464	15,310 New	15,310 $61,000

Others Institutions Holding EVGN

# of Institutions

Shares Held

3.9M

Call Options Held

400

Put Options Held

View Full List

About Evogene Ltd.

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $94.4M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

More about EVGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Evogene Ltd. Transaction History